S&P 500   3,266.38 (+0.61%)
DOW   26,916.52 (+0.38%)
QQQ   267.93 (+0.96%)
AAPL   110.04 (+1.68%)
MSFT   205.76 (+1.26%)
FB   250.40 (+0.35%)
GOOGL   1,422.34 (-0.04%)
AMZN   3,041.23 (+0.71%)
TSLA   404.71 (+4.36%)
NVDA   504.53 (+2.15%)
BABA   267.19 (-0.94%)
CGC   13.99 (-1.96%)
GE   6.03 (-0.50%)
MU   48.14 (-2.69%)
AMD   76.34 (+0.69%)
T   27.77 (-0.96%)
F   6.52 (-2.10%)
ACB   4.99 (-4.04%)
GILD   61.93 (-0.51%)
NFLX   475.99 (+0.62%)
DIS   122.15 (-0.28%)
BAC   23.23 (-0.47%)
BA   150.50 (+3.05%)
S&P 500   3,266.38 (+0.61%)
DOW   26,916.52 (+0.38%)
QQQ   267.93 (+0.96%)
AAPL   110.04 (+1.68%)
MSFT   205.76 (+1.26%)
FB   250.40 (+0.35%)
GOOGL   1,422.34 (-0.04%)
AMZN   3,041.23 (+0.71%)
TSLA   404.71 (+4.36%)
NVDA   504.53 (+2.15%)
BABA   267.19 (-0.94%)
CGC   13.99 (-1.96%)
GE   6.03 (-0.50%)
MU   48.14 (-2.69%)
AMD   76.34 (+0.69%)
T   27.77 (-0.96%)
F   6.52 (-2.10%)
ACB   4.99 (-4.04%)
GILD   61.93 (-0.51%)
NFLX   475.99 (+0.62%)
DIS   122.15 (-0.28%)
BAC   23.23 (-0.47%)
BA   150.50 (+3.05%)
S&P 500   3,266.38 (+0.61%)
DOW   26,916.52 (+0.38%)
QQQ   267.93 (+0.96%)
AAPL   110.04 (+1.68%)
MSFT   205.76 (+1.26%)
FB   250.40 (+0.35%)
GOOGL   1,422.34 (-0.04%)
AMZN   3,041.23 (+0.71%)
TSLA   404.71 (+4.36%)
NVDA   504.53 (+2.15%)
BABA   267.19 (-0.94%)
CGC   13.99 (-1.96%)
GE   6.03 (-0.50%)
MU   48.14 (-2.69%)
AMD   76.34 (+0.69%)
T   27.77 (-0.96%)
F   6.52 (-2.10%)
ACB   4.99 (-4.04%)
GILD   61.93 (-0.51%)
NFLX   475.99 (+0.62%)
DIS   122.15 (-0.28%)
BAC   23.23 (-0.47%)
BA   150.50 (+3.05%)
S&P 500   3,266.38 (+0.61%)
DOW   26,916.52 (+0.38%)
QQQ   267.93 (+0.96%)
AAPL   110.04 (+1.68%)
MSFT   205.76 (+1.26%)
FB   250.40 (+0.35%)
GOOGL   1,422.34 (-0.04%)
AMZN   3,041.23 (+0.71%)
TSLA   404.71 (+4.36%)
NVDA   504.53 (+2.15%)
BABA   267.19 (-0.94%)
CGC   13.99 (-1.96%)
GE   6.03 (-0.50%)
MU   48.14 (-2.69%)
AMD   76.34 (+0.69%)
T   27.77 (-0.96%)
F   6.52 (-2.10%)
ACB   4.99 (-4.04%)
GILD   61.93 (-0.51%)
NFLX   475.99 (+0.62%)
DIS   122.15 (-0.28%)
BAC   23.23 (-0.47%)
BA   150.50 (+3.05%)
Log in
NASDAQ:RPTX

Repare Therapeutics Stock Forecast, Price & News

$30.14
-2.53 (-7.74 %)
(As of 09/25/2020 03:45 AM ET)
Add
Compare
Today's Range
$29.98
Now: $30.14
$32.51
50-Day Range
$23.28
MA: $27.06
$33.92
52-Week Range
$21.45
Now: $30.14
$36.67
Volume983 shs
Average Volume108,493 shs
Market Capitalization$1.11 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for Repare Therapeutics Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.60 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:RPTX
CUSIPN/A
CIKN/A
Phone857-412-7018

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$1.11 billion
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
$30.14
-2.53 (-7.74 %)
(As of 09/25/2020 03:45 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RPTX News and Ratings via Email

Sign-up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Repare Therapeutics (NASDAQ:RPTX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Repare Therapeutics?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Repare Therapeutics in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Repare Therapeutics
.

When is Repare Therapeutics' next earnings date?

Repare Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Repare Therapeutics
.

How were Repare Therapeutics' earnings last quarter?

Repare Therapeutics (NASDAQ:RPTX) issued its quarterly earnings data on Thursday, August, 13th. The company reported ($2.45) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.44) by $2.01.
View Repare Therapeutics' earnings history
.

What price target have analysts set for RPTX?

5 brokers have issued 12-month target prices for Repare Therapeutics' stock. Their forecasts range from $27.00 to $40.00. On average, they anticipate Repare Therapeutics' share price to reach $34.67 in the next twelve months. This suggests a possible upside of 15.0% from the stock's current price.
View analysts' price targets for Repare Therapeutics
.

Who are some of Repare Therapeutics' key competitors?

What other stocks do shareholders of Repare Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Repare Therapeutics investors own include Boeing (BA), Marvell Technology Group (MRVL), Norwegian Cruise Line (NCLH), Adobe (ADBE), Albertsons Companies (ACI), Abbott Laboratories (ABT), AmerisourceBergen (ABC), AES (AES), Autodesk (ADSK) and Apache (APA).

When did Repare Therapeutics IPO?

(RPTX) raised $126 million in an initial public offering (IPO) on Friday, June 19th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. Morgan Stanley, Goldman Sachs, Cowen and Piper Sandler acted as the underwriters for the IPO.

What is Repare Therapeutics' stock symbol?

Repare Therapeutics trades on the NASDAQ under the ticker symbol "RPTX."

When does the company's lock-up period expire?

Repare Therapeutics' lock-up period expires on Wednesday, December 16th. Repare Therapeutics had issued 11,000,000 shares in its public offering on June 19th. The total size of the offering was $220,000,000 based on an initial share price of $20.00. After the end of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Who are Repare Therapeutics' major shareholders?

Repare Therapeutics' stock is owned by many different retail and institutional investors. Top institutional investors include Orbimed Advisors LLC (9.78%), MPM Asset Management LLC (8.58%), FMR LLC (6.88%), CHI Advisors LLC (7.15%), BVF Inc. IL (5.55%) and Logos Global Management LP (1.90%).

Which institutional investors are buying Repare Therapeutics stock?

RPTX stock was bought by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, MPM Asset Management LLC, FMR LLC, CHI Advisors LLC, BVF Inc. IL, Logos Global Management LP, Artal Group S.A., and CHI Advisors LLC.

How do I buy shares of Repare Therapeutics?

Shares of RPTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Repare Therapeutics' stock price today?

One share of RPTX stock can currently be purchased for approximately $30.14.

How big of a company is Repare Therapeutics?

Repare Therapeutics has a market capitalization of $1.11 billion.

What is Repare Therapeutics' official website?

The official website for Repare Therapeutics is www.reparerx.com.

How can I contact Repare Therapeutics?

Repare Therapeutics' mailing address is 7210 Frederick-Banting Suite 100, St-Laurent A8, H4S 2A1. The company can be reached via phone at 857-412-7018 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.